| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 09/30/2004 | WO2004082633A2 A method of treating a systemic disease |
| 09/30/2004 | WO2004082626A2 Aromatase inhibitor diagnosis and therapy |
| 09/30/2004 | WO2004082625A2 Self-emulsifying compositions, methods of use and preparation |
| 09/30/2004 | WO2004082615A2 A process for preparing sustained release tablets |
| 09/30/2004 | WO2004082612A2 Liposomal formulations and methods of use |
| 09/30/2004 | WO2004082607A2 A method of preparing gas-filled polymer matrix microparticles useful for delivering drug |
| 09/30/2004 | WO2004082594A2 Alginate sponge and preparation method thereof |
| 09/30/2004 | WO2004082590A2 A low dose corticosteroid composition |
| 09/30/2004 | WO2004082589A2 Nasally administrable, bioavailable pharmaceutical composition of loratadine |
| 09/30/2004 | WO2004082587A2 Stable lamotrigine pharmaceutical compositions and processes for their preparation |
| 09/30/2004 | WO2004082580A2 Photostabilized topical formulations of ketoprofen containing two uv filters |
| 09/30/2004 | WO2004082576A2 Direct compressible trehalose solids |
| 09/30/2004 | WO2004082564A2 Coated enzyme granules |
| 09/30/2004 | WO2004082525A2 Sinus delivery of sustained release therapeutics |
| 09/30/2004 | WO2004082378A1 Method of inhibiting freeze concentrating of substance in wet material, method of inhibiting deactivation of physiologically active substance, and process for producing lyophilizate or frozen matter having component homogeneously diffused therein |
| 09/30/2004 | WO2004071487A3 Controlled release device and method |
| 09/30/2004 | WO2004066986A9 Thin film with non-self-aggregating uniform heterogeneity and drug delivery systems made therefrom |
| 09/30/2004 | WO2004065578A3 Microparticles comprising polynucleotide adsorbed on the surface of or entrapped within the microparticles |
| 09/30/2004 | WO2004064912A8 An otorhinological delivery device |
| 09/30/2004 | WO2004064815A8 Oral dosage formulation |
| 09/30/2004 | WO2004062651A8 Pharmaceutical aerosol composition |
| 09/30/2004 | WO2004060351A3 Pharmaceutical formulation with an insoluble active agent for pulmonary administration |
| 09/30/2004 | WO2004060315A3 Stable topical drug delivery compositions |
| 09/30/2004 | WO2004058218A3 Prefilming atomizer |
| 09/30/2004 | WO2004058138A3 Oil composition based on peroxidised lipids, which can be used in the treatment of xerostomia |
| 09/30/2004 | WO2004054540A3 Solid compositions with improved bio-availability of insoluble or poorly water soluble drugs and a corresponding process for preparing such |
| 09/30/2004 | WO2004052337A3 Nasal pharmaceutical preparation containing an active lipophilic liquid or gaseous ingredient |
| 09/30/2004 | WO2004050058A3 Pharmaceutical compositions comprising a basic respectively acidic drug compound, a surfactant and a physiologically tolerable water-soluble acid respectively base |
| 09/30/2004 | WO2004049918A3 A system for administering a combination of therapies to a body lumen |
| 09/30/2004 | WO2004047796A3 Pulverulent formulation for inhalation containing tiotropium |
| 09/30/2004 | WO2004039392A3 Stabilized, solid-state polypeptide particles |
| 09/30/2004 | WO2004034992A3 Encapsulation and deaggregation of polyene antibiotics using poly(ethylene glycol)-phospholipid micelles |
| 09/30/2004 | WO2004032849A3 Methods of administering fgf18 |
| 09/30/2004 | WO2004030661A3 Therapeutic compositions comprising a boron-containing compound |
| 09/30/2004 | WO2004030647A3 Target-oriented formulations |
| 09/30/2004 | WO2004019871A3 Breath freshening and oral cleansing product using geraniol |
| 09/30/2004 | WO2004000235A3 Breath freshening and oral cleansing product with magnolia bark extract |
| 09/30/2004 | WO2003106629A3 Treating vitamin d responsive diseases |
| 09/30/2004 | WO2003102014A3 Compositions methods and systems for pulmonary delivery of recombinant human interferon alpha-2b |
| 09/30/2004 | WO2003101383A3 Oral pharmaceutical composition for soft capsules containing vinorelbine and method of treatment |
| 09/30/2004 | WO2003068197A8 Method for systemic drug delivery through the nail |
| 09/30/2004 | WO2003036410A3 Treatment protocol generation for diseases related to angiogenesis |
| 09/30/2004 | WO2003026623A8 Intraorally disintegrating valdecoxib compositions |
| 09/30/2004 | WO2003024396A3 Dry powder medicament formulations |
| 09/30/2004 | US20040193144 Drug delivery device |
| 09/30/2004 | US20040193137 Apparatus for the delivery of drugs or gene therapy into a patient's vasculature and methods of use |
| 09/30/2004 | US20040193126 Reduce adhesion of feces to skin; female hygiene garment |
| 09/30/2004 | US20040193090 Ambulatory medical apparatus with handheld communication device |
| 09/30/2004 | US20040192900 Calicheamicin derivative-carrier conjugates |
| 09/30/2004 | US20040192786 Use of xylitol to reduce ionic strength and activate endogenous antimicrobials for prevention and treatment of infections |
| 09/30/2004 | US20040192781 Method of administration for metoclopramide and pharmaceutical formulation therefor |
| 09/30/2004 | US20040192776 Cationic lipid compositions targeting angiogenic endothelial cells |
| 09/30/2004 | US20040192768 Aqueous solution of ascorbic acid and method for producing same |
| 09/30/2004 | US20040192760 Pharmaceutical formulations |
| 09/30/2004 | US20040192755 Immediate release medicinal compositions for oral use |
| 09/30/2004 | US20040192706 Oral administering; sustained release of ocinaplonin |
| 09/30/2004 | US20040192702 Heteroaryl alkyl piperazine derivatives |
| 09/30/2004 | US20040192690 Central nervous system disorders; side effect reduction; antiepileptic agents; analgesics; antiepileptic agents; edema; multiple sclerosis; psychological disorders; schizophrenia; bipolar disorders |
| 09/30/2004 | US20040192675 Pharmaceutical compositions containing tiotropium salts and antihistamines and their use |
| 09/30/2004 | US20040192662 Topically administering tazarotene gel and corticoid cream |
| 09/30/2004 | US20040192661 Micronized eplerenone compositions |
| 09/30/2004 | US20040192647 topically applying an aqueous ophthalmic composition comprising N-acetylcarnosine, a N-acetylcarnosine derivative and a cellulose compound which increases intraocular absorption of N-acetylcarnosine; a hydrophilic hydrogel contact lens and an ocular polymer insert for topical application |
| 09/30/2004 | US20040192641 formed from polysaccharides of kelp (PK), an anticancer and increases immunity, and new nanoparticles (NP) and special liposome (SSL), which contained natural anticancer drug; improvement of efficacy of Homoharringtonine (HHT), Curcumol (CUR), Elemene (ELE) and Camptothecin (CPT) by NP and SSL |
| 09/30/2004 | US20040192640 Use of sucralfate for the treatment of cervical erosion |
| 09/30/2004 | US20040192638 Method and composition for prolonging the residence time of drugs in the gut |
| 09/30/2004 | US20040192623 Aloe-emodin derivatives and their use in the treatment of neoplasias |
| 09/30/2004 | US20040192622 intimate admixture of azithromycin and a stabilizing amount of an antioxidant; treating a bacterial infection |
| 09/30/2004 | US20040192620 suppressing follicle maturation and ovulation and replacing the endogenous ovarian secretion of 17 beta-estradiol; 1,3,5 (10)-estratrien-3, 15 alpha ,16 alpha ,17 beta -tetrol for example; does not employ co-administration of a luteinizing hormone releasing hormone; less side effects |
| 09/30/2004 | US20040192616 Phenolic acid salts of gabapentin in solid dosage forms and methods of use |
| 09/30/2004 | US20040192595 Treatment of lung disorders |
| 09/30/2004 | US20040192589 Production of high molecular mass lectins |
| 09/30/2004 | US20040192585 Administering to a patient an amount of IRM(immune respose modifier) compound effective for treating basal cell carcinoma in a treatment cycle that includes at least two consecutive days in which the IRM compound is administered and at least one day in which the IRM compound is not administered |
| 09/30/2004 | US20040192582 An oral dosase form containing a polymer that swells upon absorbing water from gastric fluid to increase its size thereby promoting its gastric retention, maintains its physical integrity in a stomach for at least 2 hours, and is degradable by an intestinal enzyme or exposure to an intestinal pH |
| 09/30/2004 | US20040192579 Administration of the mammal a formulation containing a matrine component and dictamnine in amount effective to deliver daily amount of at least 15 mu mole of a matrine component and at least 0.15 mu mole of dictamnine/kg of body weight to treat cancer |
| 09/30/2004 | US20040191926 Ptp1b inhibitors and ligands |
| 09/30/2004 | US20040191909 Glycerol viral suspension absent of divalent metal cations or alkali metal cations and capable for presevation and storage of adenovirus particles |
| 09/30/2004 | US20040191893 Implantable drug delivery system comprised of sealed thermoplastic polymer in association with permeable membrane; gene therapy; toxicity testing |
| 09/30/2004 | US20040191722 Characterization of an antibiotic impregnated delivery system as an intracanal medicament in endodontic therapy |
| 09/30/2004 | US20040191499 Tablets with coloured patterns and preparation thereof |
| 09/30/2004 | US20040191400 High-intensity sweetener composition and delivery of same |
| 09/30/2004 | US20040191345 New formulations and use thereof |
| 09/30/2004 | US20040191332 Preserved ophthalmic compositions |
| 09/30/2004 | US20040191330 Daily skin care regimen |
| 09/30/2004 | US20040191329 Antimicrobial, atomically disordered, nanocrystalline silver components; greater penetration, coverage, efficacy |
| 09/30/2004 | US20040191326 Taste-masking vehicle for coated oxazolidinone particles |
| 09/30/2004 | US20040191325 Protecting proteins from organic solvent denaturating during encapsulation; controlling release rate and profile; application to viruses, bacteria and/or cells; diagnosis kit |
| 09/30/2004 | US20040191324 Method for preparing microparticles using liquid-liquid extraction |
| 09/30/2004 | US20040191323 Implant for subcutaneous or intradermal injection |
| 09/30/2004 | US20040191322 Physically and chemically stable nicotine-containing particulate material |
| 09/30/2004 | US20040191321 Fabricating three dimensional nonspherical shapes using differential volume shrinkage; producing materials for advanced drug delivery and cell encapsulation; simple, low cost |
| 09/30/2004 | US20040191320 Pulmonary formulation |
| 09/30/2004 | US20040191319 Process for the controlled production of organic particles |
| 09/30/2004 | US20040191316 Washable, water resistant adhesive; crosslinked copolymer from such as acrylamide, diethyleneglycol methacrylate, n,n-methylenebisacrylamide, hexaglycerin and polyethyleneglycol; reusable bioelectrodes |
| 09/30/2004 | US20040191314 Having lubricating gelatinous layer preventing crack formation in semipermeable wall during dispensing |
| 09/30/2004 | US20040191313 Solid, accurately dosable pharmaceutical presentations for individual dispensing from dosing devices and methods thereof |
| 09/30/2004 | US20040191312 Preventing reperfusion injury following stroke; restoring brain cell function; 1-(m-chlorophenyl)-biguanide, N-phenyl-imidocarbonimidicdiamide, 2-methyl-5-hydroxytryptaminemaleate, 2-(1-(4-methyl)-piperazineyl)quinolinedimaleate and/or 1-(6-chloro-2-pyridinyl)-4-piperidinamine |
| 09/30/2004 | US20040191309 Trans-tetracos-15-enoic acid and andrographolide; nontoxic, side effect free |
| 09/30/2004 | US20040191308 Producing intraocular suture tab; uniform, accurate, economic; forming one large and multiple small aperatures in hydrophobic polymeric capsule; filling with medicant and covering with hydrophilic polymer |
| 09/30/2004 | US20040191307 Therapeutic liposome composition and method of preparation |
| 09/30/2004 | US20040191306 composition that includes a charged lipid for interaction with a charged therapeutic agent, yet which bears minimal external surface charge after formation. |